Rita Moretti Selected Research

Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy)

11/2020	Behavior in subcortical vascular dementia with sight pathologies: visual hallucinations as a consequence of precocious gait imbalance and institutionalization.
9/2020	An Iatrogenic Model of Brain Small-Vessel Disease: Post-Radiation Encephalopathy.
1/2019	Small vessel disease to subcortical dementia: a dynamic model, which interfaces aging, cholinergic dysregulation and the neurovascular unit.
1/2017	Vitamin D, Homocysteine, and Folate in Subcortical Vascular Dementia and Alzheimer Dementia.
4/2008	Different responses to rivastigmine in subcortical vascular dementia and multi-infarct dementia.
10/2005	Olanzapine as a possible treatment of behavioral symptoms in vascular dementia: risks of cerebrovascular events. A controlled, open-label study.
3/2005	Neuropsychological evaluation of late-onset post-radiotherapy encephalopathy: a comparison with vascular dementia.
11/2004	Cholinesterase inhibition as a possible therapy for delirium in vascular dementia: a controlled, open 24-month study of 246 patients.
6/2004	Rivastigmine in vascular dementia.
3/2004	Olanzapine as a possible treatment for anxiety due to vascular dementia: an open study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rita Moretti Research Topics

Disease

14	Dementia (Dementias) 11/2020 - 04/2002
13	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 11/2020 - 11/2002
7	Alzheimer Disease (Alzheimer's Disease) 01/2017 - 01/2003
5	Inflammation (Inflammations) 04/2022 - 05/2019
4	Parkinson Disease (Parkinson's Disease) 06/2021 - 10/2002
3	Stroke (Strokes) 01/2022 - 01/2019
3	Vitamin D Deficiency 01/2022 - 01/2017
3	Hyperhomocysteinemia 01/2019 - 09/2004
3	Parkinsonian Disorders (Parkinsonism) 05/2006 - 03/2004
2	Disease Progression 03/2022 - 07/2021
2	Chronic Disease (Chronic Diseases) 06/2021 - 11/2020
2	Pain (Aches) 01/2018 - 01/2002
2	Neuralgia (Stump Neuralgia) 01/2018 - 01/2002
2	Cognitive Dysfunction 01/2017 - 09/2004
2	Frontotemporal Dementia (Semantic Dementia) 01/2004 - 01/2003
1	Hypoxia (Hypoxemia) 03/2022
1	Diabetes Mellitus 01/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022
1	Anemia 01/2022
1	Insulin Resistance 01/2022
1	Fibrosis (Cirrhosis) 12/2021
1	Liver Cirrhosis (Hepatic Cirrhosis) 12/2021
1	Infections 12/2021
1	COVID-19 07/2021
1	Intestinal Diseases (Diseases, Intestinal) 07/2021
1	Hearing Loss (Hearing Impairment) 12/2020
1	Neonatal Hyperbilirubinemia 12/2020
1	Coronary Artery Disease (Coronary Atherosclerosis) 12/2020
1	Myocardial Ischemia (Ischemic Heart Diseases) 12/2020
1	Reperfusion Injury 12/2020
1	Hallucinations (Hallucination) 11/2020
1	Neoplasms (Cancer) 09/2020
1	Non-alcoholic Fatty Liver Disease 07/2019
1	Atherosclerosis 01/2019
1	Nervous System Diseases (Neurological Disorders) 07/2018
1	Liver Diseases (Liver Disease) 03/2018
1	Restless Legs Syndrome (Restless Legs) 03/2018
1	Cryoglobulinemia 01/2018
1	Hepatitis C 01/2018
1	Painful Neuropathy 01/2018
1	Multi-Infarct Dementia (Dementia, Multi Infarct) 04/2008
1	Peripheral Nervous System Diseases (PNS Diseases) 07/2006
1	Psychomotor Agitation (Akathisia) 10/2005
1	Vascular System Injuries 03/2005
1	Brain Diseases (Brain Disorder) 03/2005
1	Lewy Body Disease (Lewy Body Dementia) 11/2004
1	Delirium 11/2004
1	Pernicious Anemia 09/2004
1	Avitaminosis (Vitamin Deficiency) 09/2004

Drug/Important Bio-Agent (IBA)

8	Rivastigmine (Exelon)FDA LinkGeneric 01/2017 - 11/2002
5	Folic Acid (Vitamin M)FDA LinkGeneric 07/2019 - 09/2004
4	Cholinergic Agents (Cholinergics)IBA 01/2019 - 11/2002
4	Gabapentin (Neurontin)FDA LinkGeneric 01/2018 - 01/2002
3	Vitamin D FDA LinkGeneric 01/2022 - 01/2017
3	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 07/2019 - 09/2004
3	HomocysteineIBA 07/2019 - 01/2017
3	Psychotropic Drugs (Psychoactive Drugs)IBA 05/2006 - 03/2004
3	Olanzapine (Zyprexa)FDA Link 10/2005 - 07/2003
3	ButyrylcholinesteraseIBA 11/2004 - 11/2002
3	AcetylcholinesteraseIBA 11/2004 - 11/2002
2	Pharmaceutical PreparationsIBA 12/2021 - 06/2015
2	BilirubinIBA 06/2021 - 12/2020
2	LipidsIBA 12/2020 - 07/2019
2	VitaminsIBA 11/2019 - 07/2019
2	Vitamin B Complex (B Vitamins)IBA 11/2019 - 01/2019
2	Oxcarbazepine (Trileptal)FDA LinkGeneric 01/2018 - 07/2006
1	Interleukin-6 (Interleukin 6)IBA 04/2022
1	C-Reactive ProteinIBA 04/2022
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2022
1	Matrix Metalloproteinases (MMPs)IBA 03/2022
1	Biomarkers (Surrogate Marker)IBA 03/2022
1	NeuroglobinIBA 03/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2021
1	Complement System Proteins (Complement)IBA 07/2021
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 07/2021
1	Glutamic Acid (Glutamate)FDA Link 12/2020
1	CurcuminIBA 12/2020
1	Amyloid (Amyloid Fibrils)IBA 12/2020
1	Biological ProductsIBA 11/2020
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 09/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 11/2019
1	CholesterolIBA 07/2019
1	chloroethylaminouracilIBA 05/2019
1	Pregabalin (Lyrica)FDA Link 01/2018
1	SteroidsIBA 01/2018
1	CryoglobulinsIBA 01/2018
1	Nimodipine (Modus)FDA LinkGeneric 04/2008
1	Therapeutic UsesIBA 04/2008
1	Antipsychotic Agents (Antipsychotics)IBA 05/2006
1	Cholinesterases (Cholinesterase)IBA 11/2004
1	Acetylcholine (Acetylcholine Chloride)FDA Link 11/2004
1	EnzymesIBA 09/2004
1	CarbonIBA 09/2004

Therapy/Procedure

11	Therapeutics 03/2022 - 01/2002
2	Radiotherapy 09/2020 - 03/2005
2	Drug Therapy (Chemotherapy) 03/2004 - 10/2002
1	Phototherapy (Light Therapy) 12/2020
1	Institutionalization (Institutionalized Persons) 11/2020
1	Cranial Irradiation 03/2005